HCPCS Code G2083
Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation
| Short Description | Visit esketamine, > 56m |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | January 01, 2020 |
| Code Added Date | January 01, 2020 |
| Pricing Indicator | 13 = Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion) |
| Type of Service | 1 = Medical care |